{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:32:01Z","timestamp":1767961921971,"version":"3.49.0"},"reference-count":74,"publisher":"Japanese Circulation Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1253\/circj.cj-10-0153","type":"journal-article","created":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T02:30:13Z","timestamp":1271298613000},"page":"827-835","source":"Crossref","is-referenced-by-count":91,"title":["Oxidative Stress and Central Cardiovascular Regulation - Pathogenesis of Hypertension and Therapeutic Aspects -"],"prefix":"10.1253","volume":"74","author":[{"given":"Yoshitaka","family":"Hirooka","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Sagara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Kishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sunagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: Achievements and perspectives. Hypertension 2009; 54: 690-697.","DOI":"10.1161\/HYPERTENSIONAHA.108.119883"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Esler M. Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: The transition from mechanisms to medical management. J Appl Physiol 2010; 108: 227-237.","DOI":"10.1152\/japplphysiol.00832.2009"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006; 7: 335-346.","DOI":"10.1038\/nrn1902"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74: 323-364.","DOI":"10.1152\/physrev.1994.74.2.323"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200209000-00002"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-003-0030-0"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Campos RR, Bergamaschi CT. Neurotransmission alterations in central cardiovascular control in experimental hypertension. Curr Hypertens Rev 2006; 2: 193-198.","DOI":"10.2174\/157340206778132590"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.05.001"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2008.06.001"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-006-0056-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Campos RR. Oxidative stress in the brain and arterial hypertension. Hypertens Res 2009; 32: 1047-1048.","DOI":"10.1038\/hr.2009.180"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000043501.47934.FA"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000135483.12297.e4"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000128695.49900.12"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ohtsuki T, Matsumoto M, Suzuki K, Taniguchi N, Kamada T. Mitochondrial lipid peroxidation and superoxide dismutase in rat hypertensive target organs. Am J Physiol Heart Circ Physiol 1995; 268: H1418-H1421.","DOI":"10.1152\/ajpheart.1995.268.4.H1418"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(99)00623-0"},{"issue":"2\/3","key":"17","first-page":"116","volume":"1362","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0005-2728","issn-type":"print"},{"issue":"3","key":"18","first-page":"641","volume":"42","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/1039-9712","issn-type":"print"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tai MH, Wang LL, Wu KL, Chan JY. Increased superoxide anion in rostral ventrolateral medulla contributes to hypertension in spontaneously hypertensive rats via interactions with nitric oxide. Free Radic Biol Med 2005; 38: 450-462.","DOI":"10.1016\/j.freeradbiomed.2004.11.015"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Chan SHH, Tai MH, Li CY, Chan JYH. Reduction in molecular synthesis or enzyme activity of superoxide dismutase and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic Biol Med 2006; 40: 2028-2039.","DOI":"10.1016\/j.freeradbiomed.2006.01.032"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Oliveira-Sales EB, Dugaich AP, Carillo BA, Abreu NP, Boim MA, Martins PJ, et al. Oxidative stress contributes to renovascular hypertension. Am J Hypertens 2008; 21: 98-104.","DOI":"10.1038\/ajh.2007.12"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Oliveira-Sales EB, Nishi EE, Carillo BA, Boim MA, Dolnikoff MS, Bergamaschi CT, et al. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 2009; 22: 484-492.","DOI":"10.1038\/ajh.2009.17"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lassegue B, Clempus RE. Vascular NAD(P)H oxidases: Specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 2003; 285: R277-R297.","DOI":"10.1152\/ajpregu.00758.2002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wang G, Anrather J, Huang J, Speth RC, Pickel VM, Iadecola C. NADPH oxidase contributes angiotensin signaling in the nucleus tractus solitarius. J Neorosci 2004; 24: 5516-5524.","DOI":"10.1523\/JNEUROSCI.1176-04.2004"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000236647.55200.07"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zimmerman MC, Dunlay RP, Larzartigues E, Zhang Y, Sharma RV, Engelhardt JF, et al. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ Res 2004; 95: 532-539.","DOI":"10.1161\/01.RES.0000139957.22530.b9"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.553370"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.087981"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32830dd5d3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Chan SHH, Wu KLH, Chang AYW, Tai MH, Chan JYH. Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Hypertension 2009; 53: 217-227.","DOI":"10.1161\/HYPERTENSIONAHA.108.116905"},{"key":"31","unstructured":"31. Zimmerman MC, Zucker IH. Mitochondrial dysfunction and mitochondrial-produced reactive oxygen species: New targets for neurogenic hypertension? Hypertension 2009; 53: 112-114."},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000152965.75127.9d"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kimura Y, Hirooka Y, Kishi T, Ito K, Sagara Y, Sunagawa K. Role of inducible nitric oxide synthase in rostral ventrolateral medulla in blood pressure regulation in spontaneously hypertensive rats. Clin Exp Hypertens 2009; 31: 281-286.","DOI":"10.1080\/10641960902822534"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Zimmerman MC, Sharma RV, Davisson RL. Superoxide mediates angiotensin II-induced influx of extracellular calcium in neural cells. Hypertension 2005; 45: 717-723.","DOI":"10.1161\/01.HYP.0000153463.22621.5e"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Sun C, Sellers KW, Sumners C, Raizada MK. NAD(P)H oxidase inhibition attenuates neuronal chronotropic actions of angiotensin II. Circ Res 2005; 96: 659-666.","DOI":"10.1161\/01.RES.0000161257.02571.4b"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Chan SHH, Hsu KS, Hunag CC, Wang LL, Ou CC, Chan JYH. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res 2005; 97: 772-780.","DOI":"10.1161\/01.RES.0000185804.79157.C0"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Kishi T, Hirooka Y, Konno S, Ogawa K, Sunagawa K. Angiotensin II type 1 receptor-activated caspase-3 through Ras\/mitogen-activated protein kinase\/extracellular signal-regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats. Hypertension 2010; 55: 291-297.","DOI":"10.1161\/HYPERTENSIONAHA.109.138636"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Reja V, Goodchild AK, Phillips JK, Pilowsky PM. Upregulation of angiotensin AT<sub>1<\/sub> receptor and intracellular kinase gene expression in hypertensive rats. Clin Exp Pharmacol Physiol 2006; 33: 690-695.","DOI":"10.1111\/j.1440-1681.2006.04420.x"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. McKinley MJ, Albiston AL, Allen AM, Mathai M, May CN, McAllen RM, et al. The brain renin-angiotensin system: Location and physiological roles. Int J Biochem Cell Biol 2003; 35: 901-918.","DOI":"10.1016\/S1357-2725(02)00306-0"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2002.03658.x"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Wang JM, Tan J, Leenen FHH. Central nervous system blockade by peripheral administration of AT<sub>1<\/sub> receptor blockers. J Cardiovasc Pharmacol 2003; 41: 593-599.","DOI":"10.1097\/00005344-200304000-00012"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Culman J, Blume A, Gohlke P, Unger T. The renin-angiotensin system in the brain: Possible therapeutic implications for AT<sub>1<\/sub>-receptor blockers. J Hum Hypertens 2002; 16: S64-S70.","DOI":"10.1038\/sj.jhh.1001442"},{"issue":"1","key":"43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3565(24)29352-6","volume":"298","author":"GOHLKE P","year":"2001","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(00)02377-5"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000135215.75876.41"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1161\/hs0102.100208"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Sagara Y, Hirooka Y, Nozoe M, Koga Y, Sunagawa K. Contribution of angiotensin II in the increased reactive oxygen species in rostral ventrolateral medulla and enhanced central sympathetic outflow in stroke-prone spontaneously hypertensive rats. Circulation 2006; 114(Suppl II): 271.","DOI":"10.1096\/fasebj.20.4.A357-a"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2009.160"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(00)00184-2"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Lin Y, Matsumura K, Kagiyama S, Fukuhara M, Fujii K, Iida M. Chronic administration of olmesartan attenuates the exaggerated pressor response to glutamate in the rostral ventrolateral medulla of SHR. Brain Res 2005; 1058: 161-166.","DOI":"10.1016\/j.brainres.2005.07.070"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2009.200"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Mogi M, Horiuchi M. Remote control of brain angiotensin II levels by angiotensin receptor blockers. Hypertens Res 2010; 33: 116-117.","DOI":"10.1038\/hr.2009.209"},{"key":"53","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318192690e"},{"key":"54","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.49"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Kimura Y, Hirooka Y, Sagara Y, Sunagawa K. Long-acting calcium channel blocker, azelnidipine, increases endothelial nitric oxide synthase in the brain and inhibits sympathetic nerve activity. Clin Exp Hypertens 2007; 29: 13-21.","DOI":"10.1080\/10641960601096745"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Sakai K, Hirooka Y, Matsuo I, Eshima K, Shigematsu H, Shimokawa H, et al. Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo. Hypertension 2000; 36: 1023-1028.","DOI":"10.1161\/01.HYP.36.6.1023"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Kishi T, Hirooka Y, Sakai K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 2001; 38: 896-901.","DOI":"10.1161\/hyp.38.4.896"},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1161\/hy0202.102701"},{"key":"59","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000050649.30821.CB"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Kishi T, Hirooka Y, Shimokawa H, Takeshita A, Sunagawa K. Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 2008; 30: 1-9.","DOI":"10.1080\/10641960701813429"},{"key":"61","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e3181ce9681"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Kishi T, Hirooka Y, Konno S, Sunagawa K. Atorvastatin improves the impaired baroreflex sensitivity via anti-oxidant effect in the rostral ventrolateral medulla of SHRSP. Clin Exp Hypertens 2009; 31: 698-704.","DOI":"10.3109\/10641960903407066"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200302000-00030"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Huang BS, Amin S, Leenen FHH. The central role of the brain in salt-sensitive hypertension. Curr Opin Cardiol 2006; 21: 295-304.","DOI":"10.1097\/01.hco.0000231398.64362.94"},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2005.04206.x"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.31.2075"},{"key":"67","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.091009"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Ito K, Hirooka Y, Sunagawa K. Acquisition of brain Na sensitivity contributes to salt-induced sympathoexcitation and cardiac dysfunction in mice with pressure overload. Circ Res 2009; 104: 1004-1011.","DOI":"10.1161\/CIRCRESAHA.108.188995"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-08-0886"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Oda E, Kawai R. Significance of heart rate in the prevalence of metabolic syndrome and its related risk factors in Japanese. Circ J 2009; 73: 1431-1436.","DOI":"10.1253\/circj.CJ-08-1142"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S, et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007; 25: 909-920.","DOI":"10.1097\/HJH.0b013e328048d004"},{"key":"72","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-09-0364"},{"key":"73","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-09-0305"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Yamamoto K, Sakata Y, Ohtani T, Takeda Y, Mano T. Heart failure with preserved ejection fraction: What is known and unknown. Circ J 2009; 73: 404-410.","DOI":"10.1253\/circj.CJ-08-1073"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/74\/5\/74_CJ-10-0153\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:51:11Z","timestamp":1740012671000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/circj\/74\/5\/74_CJ-10-0153\/_article"}},"subtitle":["\u2013 Pathogenesis of Hypertension and Therapeutic Aspects \u2013"],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-10-0153","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}